|
|
|
|
|
by Spare_account
1869 days ago
|
|
>but it's because we update them every year. OK, this is the part I wasn't aware of. I assumed (dangerous, I know) that each year's 'new' flu vaccine was really just a new 'blend' of existing proven vaccines, for the most prevalent strains that year. Edited to remove badly conceived question. New Question: How often do we have to develop novel vaccines for new Flu variants? |
|
That being said, the process generally doesn't change — you still grow and kill (or grow and weaken) viruses the same way, you just start from a different base strain. For already-approved inactivated-virus flu vaccines, the FDA does not require new clinical trials for strain updates, and for already-approved attenuated virus vaccines, they only require very minimal trials (300 adults to prove adequate attenuation) [2]. So they're not novel in the sense of the COVID vaccines, which needed large scale clinical trials to prove efficacy — the flu vaccines have generally already proved efficacy, so for strain updates the most they need to prove is safety.
1: https://en.m.wikipedia.org/wiki/Influenza_vaccine
2: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947948/